Drug Product Listings

Please note - this is not a complete list of products available in Canada. For a complete list of drug products marketed in Canada, visit the Health Canada Drug Product Database
A (35) | B (19) | C (21) | D (34) | E (35) | F (11) | G (9) | H (9) | I (21) | K (1) | L (24) | M (12) | N (6) | O (10) | P (27) | R (14) | S (24) | T (26) | U (3) | V (12) | W (1) | Z (4)
Generic Namesort icon Common Trade Name(s) Classification Date Marketed in Canada (yyyy/mm/dd)
Ruxolitinib Jakavi Antineoplastic agent 2012/07/18
Rupatadine Rupall Antihistamine, second generation 2017/01/25
Rufinamide Banzel Antiepileptic 2011/09
Rotigotine Neupro Antiparkinsonian agent / Dopamine agonist 2013/09/12
Rosiglitazone + glimepiride Avandaryl 2011/03/31
Romosozumab Evenity Bone formation agent 2019/08/12
Roflumilast Daxas Phosphodiesterase 4 (PDE4) Inhibitor 2010/11/25
Risedronate sodium Actonel Bisphosphonate
Risedronate + Calcium carbonate Actonel APC
Risedronate Actonel DR Bone metabolism regulator 2011/09/28
Risankizumab Skyrizi Interleukin-23 inihbitor 2019/05/13
Rilpivirine Edurant Antiviral agent 2011/08/08
Ribociclib Kisqali Antineoplastic agent 2018/11/26
Regorafenib Stivarga Antineoplastic agent 2013/03/11
Syndicate content